| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | +126.0% |
| Cost of Revenue | $3.1M | +64.6% |
| Gross Profit | $4.6M | +201.9% |
| R&D Expense | $2.7M | +33.3% |
| SG&A Expense | $19.8M | +55.0% |
| Interest Expense | $380K | +150.0% |
| Pre-tax Income | -$29.1M | -88.0% |
| Net Income | -$29.1M | -88.0% |
| EPS (Basic) | -$0.67 |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | +448.1% |
| Accounts Receivable | $2.0M | +31.9% |
| Inventory | $843K | +209.3% |
| Current Assets | $15.3M | +254.6% |
| Total Assets | $16.7M | +275.8% |
| Current Liabilities | $4.9M | -53.6% |
| Total Liabilities | $18.8M | +67.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | -36.8% |
| Capital Expenditures | $30K | — |
| Investing Cash Flow | -$30K | — |
| Financing Cash Flow | $25.2M | +106.2% |
| Free Cash Flow | -$15.2M | — |
| -51.8% |
| Stockholders' Equity |
| -$2.1M |
| +68.6% |